Adicet Bio, Inc. (ACET)

Adicet Bio, Inc. (ACET) is a healthcare company (biotechnology) based in the United States. The share price is $2.79, up 1.45% on the day, which values the company at $26.12M. Price as of 17 Nov 2026, 17:28 UTC, from Yahoo Finance.

Key facts

Share price
$2.79+1.45% today
Market value
$26.12M
200-week average
$27.2990% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Adicet Bio, Inc. in more detail

ACET trades at -0.6× next year's expected earnings. It sits 90% below its 200-week average of $27.29.

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Share count keeps rising.

1 of the superinvestors tracked here hold ACET, including Peter Kolchinsky (0.1% of the portfolio).

Superinvestors holding ACET

1 of the investors tracked here report a position in their latest 13F filing.

Adicet Bio, Inc. (ACET): questions and answers

What is Adicet Bio, Inc.'s market cap?

Adicet Bio, Inc. is valued at $26.12M at a share price of $2.79.

Is ACET above its 200-week moving average?

No. ACET is 89.8% below its 200-week average of $27.29. Long-term investors watch that line because strong companies rarely trade below it for long.

Does ACET pay a dividend?

Adicet Bio, Inc. does not currently pay a regular dividend.

Which famous investors own ACET?

In their latest quarterly filings, Peter Kolchinsky (0.1% of the portfolio) hold ACET. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Adicet Bio, Inc. (ACET) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/ACET

Underlying data: Yahoo Finance; company filings with the SEC.